Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Human Genome Sciences initiates phase II clinical trial of repifermin for mucositis

Jan. 21, 2000

Pharmacia & Upjohn and Geron extend telomerase collaboration

Jan. 21, 2000

Myriad Genetics patent covers p19 therapeutic and diagnostic development

Jan. 20, 2000

Joint venture formed by Ribozyme and Elan to develop anticancer ribozyme product

Jan. 20, 2000

Clinical trial commences with Cell Therapeutics' novel paclitaxel

Jan. 20, 2000

Magainin presents new anticancer magainin peptide at H&Q

Jan. 20, 2000

First clinical results with 90Y-DOTATOC indicate antitumor efficacy, some safety problems

Jan. 19, 2000

CKD-731: new fumagillin analogue shows potential as antiangiogenic agent

Jan. 19, 2000

Distamycin derivatives in development at Pharmacia & Upjohn

Jan. 19, 2000

Phase I trial shows excellent safety profile for NeoRx's STR agent

Jan. 19, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...